803 related articles for article (PubMed ID: 9786472)
21. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):276-9. PubMed ID: 11399020
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
Abdel-Salam HA
Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
[TBL] [Abstract][Full Text] [Related]
23. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
Chen SC; O'Donnell ML; Gordon S; Gilbert GL
J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Mahabeer Y; Chang CC; Naidu D; Dorasamy A; Lewin S; Ndung'u T; Moosa MY; French M; Mlisana K; Coovadia Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):294-8. PubMed ID: 25277745
[TBL] [Abstract][Full Text] [Related]
25. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
Espinel-Ingroff A; Canton E; Gibbs D; Wang A
J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
[TBL] [Abstract][Full Text] [Related]
26. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Barry AL
J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients.
Silva Mdo R; Costa MR; Miranda AT; Fernandes Ode F; Costa CR; Paula CR
Rev Inst Med Trop Sao Paulo; 2002; 44(3):121-5. PubMed ID: 12163903
[TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method.
López-Jodra O; Torres-Rodríguez JM; Méndez-Vásquez R; Ribas-Forcadell E; Morera-López Y; Baró-Tomás T; Alia-Aponte C
J Antimicrob Chemother; 2000 May; 45(5):645-9. PubMed ID: 10797087
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of a new method for antifungal drugs susceptibility testing to yeasts].
Ishigaki S; Kawakami S; Ono Y; Miyazawa Y
Kansenshogaku Zasshi; 2000 Mar; 74(3):221-30. PubMed ID: 10783576
[TBL] [Abstract][Full Text] [Related]
32. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates.
Dias ALT; Matsumoto FE; Melhem MSC; da Silva EG; Auler ME; de Siqueira AM; Paula CR
J Med Microbiol; 2006 Dec; 55(Pt 12):1693-1699. PubMed ID: 17108273
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Chang HC; Chang JJ; Chan SH; Huang AH; Wu TL; Lin MC; Chang TC
J Clin Microbiol; 2001 Apr; 39(4):1328-33. PubMed ID: 11283051
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Colombo AL; Barchiesi F; McGough DA; Rinaldi MG
J Clin Microbiol; 1995 Mar; 33(3):535-40. PubMed ID: 7751353
[TBL] [Abstract][Full Text] [Related]
38. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
[TBL] [Abstract][Full Text] [Related]
39. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
Souza LK; Fernandes Ode F; Kobayashi CC; Passos XS; Costa CR; Lemos JA; Souza-Júnior AH; Silva Mdo R
Rev Inst Med Trop Sao Paulo; 2005; 47(5):253-6. PubMed ID: 16302107
[TBL] [Abstract][Full Text] [Related]
40. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
